Business Description
Entia Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US29384E1047
Description
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.03 | |||||
9-Day RSI | 1.82 | |||||
14-Day RSI | 9.55 | |||||
3-1 Month Momentum % | 500 | |||||
6-1 Month Momentum % | 100 | |||||
12-1 Month Momentum % | 500 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -272.83 | |||||
OCF Margin % | -269.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ERGO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Entia Biosciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.265 | ||
| EPS (TTM) ($) | -0.05 | ||
| Beta | 14.2169 | ||
| 3-Year Sharpe Ratio | 0.65 | ||
| 3-Year Sortino Ratio | 3.66 | ||
| Volatility % | 544.86 | ||
| 14-Day RSI | 9.55 | ||
| 14-Day ATR ($) | 0.000025 | ||
| 20-Day SMA ($) | 0.00048 | ||
| 12-1 Month Momentum % | 500 | ||
| 52-Week Range ($) | 0.0001 - 0.0402 | ||
| Shares Outstanding (Mil) | 33.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Entia Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Entia Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2012-02-15 | 0.60 (-25.00%) |
Show
Entries
Entia Biosciences Inc Frequently Asked Questions
What is Entia Biosciences Inc(ERGO)'s stock price today?
The current price of ERGO is $0.00. The 52 week high of ERGO is $0.04 and 52 week low is $0.00.
When is next earnings date of Entia Biosciences Inc(ERGO)?
The next earnings date of Entia Biosciences Inc(ERGO) is .
Does Entia Biosciences Inc(ERGO) pay dividends? If so, how much?
Entia Biosciences Inc(ERGO) does not pay dividend.
Guru Commentaries on OTCPK:ERGO
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Entia Biosciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers